Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1 Advanced Breast Cancer 1

Interventions

Letrozole 2 Anastrozole 2 trastuzumab deruxtecan 1 dalpiciclib 1 Vinorelbine 1 Standard of Care 1 Safety 1 Radiotherapy 1 In Situ Hybridization, Fluorescence 1 Gonadotropin-Releasing Hormone 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Advanced Breast Cancer × dalpiciclib × Clear all

NCT06301438 2026-02-03

Dalpiciclib in HR+/HER2- ABC

RenJi Hospital

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡